Showing results (471-480 of 878) with videos related to
Sort By:
Pageof 88
International Journal of Cardiology|March 8, 2017
Prognostic value of left atrial size and function in adults with tetralogy of FallotVivan J M Baggen, Anne-Rose W Schut, Judith A A E Cuypers, et al.European Heart Journal|January 21, 2006
Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary RevascularizationMarjo Hordijk-Trion, Mattie Lenzen, William Wijns, et al.Cardiology|October 10, 2009
Prediction of 30-day mortality in older patients with a first acute myocardial infarctionTimo Lenderink, Adrián V Hernández, Eric Boersma, et al.Cardiology|February 5, 2003
Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrelin therapy)Arno Breeman, Nestor Mercado, Mattie Lenzen, et al.Heart (British Cardiac Society)|September 19, 2006
The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary RevascularisationMattie J Lenzen, Wilma J M Scholte op Reimer, Susanne S Pedersen, et al.Journal of Cardiovascular Electrophysiology|September 30, 2005
Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest studyPhilippine Kiès, Eric Boersma, Jeroen J Bax, et al.Scientific Reports|December 10, 2025
Sex-based differences in biomarker trajectories in acute coronary syndrome patients from the BIOMArCS studyChristiane Gärtner, Monique E Ten Haaf, K Martijn Akkerhuis, et al.The American Journal of Cardiology|September 6, 2024
Impact of Stenting Long Lesions on Clinical Outcomes in Patients Presenting With Acute Coronary Syndrome and Multivessel Disease: Data From the BIOVASC TrialHala Kakar, Jacob J Elscot, Annebel de Gier, et al.British Journal of Clinical Pharmacology|January 28, 2021
No association between use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID-19 in the COvid MEdicaTion (COMET) studyRoos S G Sablerolles, Freija E F Hogenhuis, Melvin Lafeber, et al.European Heart Journal|November 24, 2006
Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patientsClaudia Ypenburg, Martin J Schalij, Gabe B Bleeker, et al.Pageof 88